Evidence-based Pre-exposure: PrEP and your patients
HIV prevention is crucial to ending the HIV pandemic. Learn more about the benefits and limitations of currently available pre-exposure prophylaxis drugs and influencing factors that determine best choice of prevention method(s) for each patient.
- To provide motivation to clinicians to treat the last 2 million HIV-positive patients and put them on effective treatment
- To extend PrEP coverage with oral medication, vaginal ring and long-acting injectables
- To promote the use of specially trained community pharmacists to extend grassroots coverage
- To treat patients effectively with Triple Therapy (ART) as a prelude to PrEP